{"id":53038,"date":"2023-01-18T15:02:27","date_gmt":"2023-01-18T14:02:27","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/livanova-to-announce-fourth-quarter-and-full-year-2022-results\/"},"modified":"2023-01-18T15:02:27","modified_gmt":"2023-01-18T14:02:27","slug":"livanova-to-announce-fourth-quarter-and-full-year-2022-results","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/livanova-to-announce-fourth-quarter-and-full-year-2022-results\/","title":{"rendered":"LivaNova to Announce Fourth-Quarter and Full-Year 2022 Results"},"content":{"rendered":"
\n

LONDON–(BUSINESS WIRE)–#advancedcirculatorysupport<\/a>–LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its fourth-quarter and full-year 2022 results on Wednesday, February 22, 2023 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its fourth-quarter and full-year 2022 results prior to the call.\n<\/p>\n

<\/a><\/p>\n

\nA live audiocast will be accessible at www.livanova.com\/events<\/a>. Listeners should log on approximately 10 minutes in advance to ensure proper setup to receive the audiocast. To listen to the conference call by telephone, dial +1 844 200 6205 (if dialing from within the U.S.) or +1 929 526 1599 (if dialing from outside the U.S.). The conference call access code is 041577. A replay will be available on the LivaNova website for 90 days following the call.\n<\/p>\n

\nAbout LivaNova<\/b>\n<\/p>\n

\nLivaNova PLC is a global medical technology and innovation company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through innovative medical technologies, delivering life-changing improvements for both the Head and Heart. Headquartered in London, LivaNova employs approximately 3,000 employees and has a presence in more than 100 countries for the benefit of patients, healthcare professionals and healthcare systems worldwide. For more information, please visit www.livanova.com<\/a>.\n<\/p>\n

\nSafe Harbor Statement<\/b>\n<\/p>\n

\nThis news release contains \u201cforward-looking statements\u201d concerning the Company\u2019s goals, beliefs, expectations, strategies, objectives, plans and underlying assumptions and other statements that are not necessarily based on historical facts. These statements include, but are not limited to, statements regarding the next Company conference call. Actual events may differ materially from those indicated in our forward-looking statements as a result of various factors, including those factors set forth in Item 1A of the Company\u2019s most recent Annual Report on Form 10-K, as supplemented by any risk factors contained in Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. LivaNova undertakes no obligation to update the information contained in this press release to reflect subsequently occurring events or circumstances.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nLivaNova Investor Relations and Media Contacts<\/b>
+1 281-895-2382
\n
Briana Gotlin<\/b>
Director, Investor Relations
\n
InvestorRelations@livanova.com<\/a>
Deanna Wilke<\/b>
VP, Corporate Communications
\n
Corporate.Communications@livanova.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

LONDON–(BUSINESS WIRE)–#advancedcirculatorysupport–LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its fourth-quarter and full-year 2022 results on Wednesday, February 22, 2023 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its fourth-quarter and full-year 2022 results prior to the call. A live … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53038","6":"format-standard","7":"category-industry"},"yoast_head":"\nLivaNova to Announce Fourth-Quarter and Full-Year 2022 Results - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/livanova-to-announce-fourth-quarter-and-full-year-2022-results\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LivaNova to Announce Fourth-Quarter and Full-Year 2022 Results - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LONDON–(BUSINESS WIRE)–#advancedcirculatorysupport–LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its fourth-quarter and full-year 2022 results on Wednesday, February 22, 2023 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its fourth-quarter and full-year 2022 results prior to the call. A live ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/livanova-to-announce-fourth-quarter-and-full-year-2022-results\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-18T14:02:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230118005021\/en\/555341\/21\/LN-Logo-Main-PANTONE.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/livanova-to-announce-fourth-quarter-and-full-year-2022-results\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/livanova-to-announce-fourth-quarter-and-full-year-2022-results\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"LivaNova to Announce Fourth-Quarter and Full-Year 2022 Results\",\"datePublished\":\"2023-01-18T14:02:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/livanova-to-announce-fourth-quarter-and-full-year-2022-results\\\/\"},\"wordCount\":358,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/livanova-to-announce-fourth-quarter-and-full-year-2022-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230118005021\\\/en\\\/555341\\\/21\\\/LN-Logo-Main-PANTONE.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/livanova-to-announce-fourth-quarter-and-full-year-2022-results\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/livanova-to-announce-fourth-quarter-and-full-year-2022-results\\\/\",\"name\":\"LivaNova to Announce Fourth-Quarter and Full-Year 2022 Results - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/livanova-to-announce-fourth-quarter-and-full-year-2022-results\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/livanova-to-announce-fourth-quarter-and-full-year-2022-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230118005021\\\/en\\\/555341\\\/21\\\/LN-Logo-Main-PANTONE.jpg\",\"datePublished\":\"2023-01-18T14:02:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/livanova-to-announce-fourth-quarter-and-full-year-2022-results\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/livanova-to-announce-fourth-quarter-and-full-year-2022-results\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/livanova-to-announce-fourth-quarter-and-full-year-2022-results\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230118005021\\\/en\\\/555341\\\/21\\\/LN-Logo-Main-PANTONE.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230118005021\\\/en\\\/555341\\\/21\\\/LN-Logo-Main-PANTONE.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/livanova-to-announce-fourth-quarter-and-full-year-2022-results\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LivaNova to Announce Fourth-Quarter and Full-Year 2022 Results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"LivaNova to Announce Fourth-Quarter and Full-Year 2022 Results - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/livanova-to-announce-fourth-quarter-and-full-year-2022-results\/","og_locale":"en_US","og_type":"article","og_title":"LivaNova to Announce Fourth-Quarter and Full-Year 2022 Results - Pharma Trend","og_description":"LONDON–(BUSINESS WIRE)–#advancedcirculatorysupport–LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its fourth-quarter and full-year 2022 results on Wednesday, February 22, 2023 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its fourth-quarter and full-year 2022 results prior to the call. A live ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/livanova-to-announce-fourth-quarter-and-full-year-2022-results\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-18T14:02:27+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230118005021\/en\/555341\/21\/LN-Logo-Main-PANTONE.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/livanova-to-announce-fourth-quarter-and-full-year-2022-results\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/livanova-to-announce-fourth-quarter-and-full-year-2022-results\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"LivaNova to Announce Fourth-Quarter and Full-Year 2022 Results","datePublished":"2023-01-18T14:02:27+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/livanova-to-announce-fourth-quarter-and-full-year-2022-results\/"},"wordCount":358,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/livanova-to-announce-fourth-quarter-and-full-year-2022-results\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230118005021\/en\/555341\/21\/LN-Logo-Main-PANTONE.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/livanova-to-announce-fourth-quarter-and-full-year-2022-results\/","url":"https:\/\/pharma-trend.com\/en\/livanova-to-announce-fourth-quarter-and-full-year-2022-results\/","name":"LivaNova to Announce Fourth-Quarter and Full-Year 2022 Results - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/livanova-to-announce-fourth-quarter-and-full-year-2022-results\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/livanova-to-announce-fourth-quarter-and-full-year-2022-results\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230118005021\/en\/555341\/21\/LN-Logo-Main-PANTONE.jpg","datePublished":"2023-01-18T14:02:27+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/livanova-to-announce-fourth-quarter-and-full-year-2022-results\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/livanova-to-announce-fourth-quarter-and-full-year-2022-results\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/livanova-to-announce-fourth-quarter-and-full-year-2022-results\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230118005021\/en\/555341\/21\/LN-Logo-Main-PANTONE.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230118005021\/en\/555341\/21\/LN-Logo-Main-PANTONE.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/livanova-to-announce-fourth-quarter-and-full-year-2022-results\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"LivaNova to Announce Fourth-Quarter and Full-Year 2022 Results"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53038","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53038"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53038\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53038"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53038"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53038"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}